Bulgaria - Gabrovo: Pharmaceutical products

Release

ID: ocds-pyfy63:2020-278545:2021-000505
Buyer: „Mnogoprofilna bolnitsa za aktivno lechenie „D-r Tota Venkova“ AD - gr. Gabrovo
Date: 2021-01-04
Language: BG
Tags: award

ID (OCID): ocds-pyfy63:2020-278545
Releases: 2020-06-16 (ocds-pyfy63:2020-278545:2020-278545)
2021-01-04 (ocds-pyfy63:2020-278545:2021-000505)

Title: Bulgaria - Gabrovo: Pharmaceutical products
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2021-01-04 - ?

ID: ocds-pyfy63:2020-278545:obj:1
Classification: CPV / 33600000
Additional classifications: CPV / 33620000
Description: 1. Кръв и кръвотворни органи B Blood and Blood Forming OrgansB03 Antianemic PreparationsB03X Other Antianemic PreparationsB03XA Other antianemic preparations1.01. Erythropoietin (Epoetin alfa) B03XA01 Erythropoietin alfa sol. inj. in pre-filled syr. 10 000 IU/1 ml фл. (амп.) 100

ID: ocds-pyfy63:2020-278545:obj:2
Classification: CPV / 33600000
Additional classifications: CPV / 33642000
Description: 2. Хормонални препарати за системно приложение, с изкл. на полови хормони и инсулини H Systemic Hormonal Preparations, excl. Sex Hormones and InsulinsH01 PItuitary and Hypothalamic Hormones and AnaloguesH01C Hypothalamic HormonesH01CB Somatostatin and analogues2.01. Octreotide H01CB02 Octreotide powd. and solv. for susp. for inj. 20 mg фл. (амп.) 122.02. Octreotide H01CB02 Octreotide powd. and solv. for susp. for inj. 30 mg фл. (амп.) 12H02 Corticosteroids for Systemic UseH02A Corticosteroids for Systemic Use, PlainH02AB Glucocorticoids2.03. Dexamethasone H02AB02 Dexamethasone sol. for inj. 4 mg/ml 1 ml фл. (амп.) 5 500

ID: ocds-pyfy63:2020-278545:obj:3
Classification: CPV / 33600000
Additional classifications: CPV / 33652000
Description: 3.01. L01AA01 Cyclophosphamide powd. for sol. for inj. 500 mg фл. (амп.) 4003.02. L01AA06 Ifosfamide powd. for sol. for inj. 2000 mg фл. (амп.) 1503.03. L01AX03 Temozolomide caps. 100 mg табл. (капс.) 3003.04. L01BA01 Methotrexate conc. for sol. for inf. 100 mg/ml 10 ml фл. (амп.) 503.05. L01BA04 Pemetrexed conc. for sol. inf. 25 mg/ml 40 ml фл. (амп.) 183.06. L01BC02 Fluorouracil (conc. for) sol. inf. 50 mg/ml 20 ml фл. (амп.) 2 2003.07. L01BC05 Gemcitabine powd. (conc. for) sol. inf. 1000 mg фл. (амп.) 3003.08. L01BC06 Capecitabine tabl. 500 mg табл.(капс.) 20 0003.09. L01BC53 Tegafur/Gimeracil/Oteracil caps. 20 mg/5,8 mg/15.8 mg табл.(капс.) 1 0083.10. L01BC59 Trifluridine/Tipiracil tabl. 15 mg/6,14 mg табл. (капс.) 7203.11. L01BC59 Trifluridine/Tipiracil tabl. 20 mg/8,19 mg табл. (капс.) 7203.12. L01CA04 Vinorelbine conc. for sol. inf. 10 mg/ml 5 ml фл. (амп.) 1003.13. L01CB01 Etoposide conc. for sol. inf. 20 mg/ml 5 ml фл. (амп.) 2503.14. L01CD01 Paclitaxel (conc. for) sol. inf. 100 mg фл

ID: ocds-pyfy63:2020-278545:obj:4
Classification: CPV / 33600000
Additional classifications: CPV / 33630000
Description: 4. Мускулно-скелетна система M Musculo-skeletal SystemM05 Drugs for Treatment of Bone DiseasesM05B Drugs Affecting Bone Structure and MineralizationM05BA Bisphosphonates4.01. Zoledronic acid M05BA08 Zoledronic acid powd. (concentrate) for sol. for inj. 4 mg + solv. фл. (амп.) 300M05BX Other drugs affecting bone structure and mineralization4.02. Denosumab M05BX04 Denosumab sol. for inj. 120 mg 1,7 ml фл. (амп.) 200

ID: ocds-pyfy63:2020-278545:obj:5
Classification: CPV / 33600000
Additional classifications: CPV / 33660000
Description: 5. Нервна система N Nervous SystemN02 AnalgesicsN02A OpioidsN02AA Natural opium alkaloids5.01. Morphine N02AA01 Morphine sol. for inj. 20 mg/ml 1ml фл. (амп.) 4 0005.02. Oxycodone N02AA05 Oxycodone caps. 10 mg (бързо освобождаване) табл. (капс.) 4 5005.03. Oxycodone N02AA05 Oxycodone caps. 20 mg (бързо освобождаване) табл. (капс.) 2 5005.04. Oxycodone N02AA05 Oxycodone modified-release tabl. 10 mg (модифицирано освобождаване) табл. (капс.) 3 5005.05. Oxycodone N02AA05 Oxycodone modified-release tabl. 20 mg (модифицирано освобождаване) табл. (капс.) 3 5005.06. Oxycodone N02AA05 Oxycodone modified-release tabl. 40 mg (модифицирано освобождаване) табл. (капс.) 1 5005.07. Oxycodone N02AA05 Oxycodone modified-release tabl. 80 mg (модифицирано освобождаване) табл. (капс.) 3005.08. Dihydrocodeine N02AA08 Dihydrocodeine modified-release tabl. 90mg табл.(капс.) 2 500N02AA5 Oxycodone, Naloxone5.09. Oxycodone, Naloxone N02AA55 Oxycodone / Naloxone prolonged release tabl. 5 mg/2,5 mg таб

ID: ocds-pyfy63:2020-278545:obj:6
Classification: CPV / 33600000
Additional classifications: CPV / 33690000
Description: 6. Разни V VariousV03 All Other Therapeutic ProductsV03A All Other Therapeutic ProductsV03AF Detoxifying agents for antineoplastic treatment6.01. Mesna V03AF01 Mesna sol. for inj. 100 mg/ml 4 ml фл. (амп.) 8006.02. Calcium folinate V03AF03 Calcium folinate conc. for sol. for inf. 10 mg/ml 5 ml фл. (амп.) 2 0006.03. Calcium folinate V03AF03 Calcium folinate conc. for sol. for inf. 10 mg/ml 10ml фл. (амп.) 3 500

ID: ocds-pyfy63:2020-278545:award:1
Title: Хормонални препарати за системно приложение, с изкл. на полови хормони и инсулини H Systemic Hormonal Preparations, excl. Sex Hormones and Insulins
Status: unsuccessful

ID: ocds-pyfy63:2020-278545:award:2
Title: Антинеопластични и имуномодулиращи средства L Antineoplastic and Immunomodulating Agents
Status: unsuccessful

Roles: buyer
Organization name: „Mnogoprofilna bolnitsa za aktivno lechenie „D-r Tota Venkova“ AD - gr. Gabrovo
Street address: ul. „D-r Iliev Detskiya“ No. 1
Locality: Gabrovo
Postal code: 5300
Country: BG
Contact name: Petya Popova — spetsialist „Obshtestveni porachki“
E-mail: targovembalgabrovo@gmail.com
Phone: +359 66800638
Fax: +359 66804424
Website: Link